Eli Lilly's (LLY) experimental obesity drug, eloralintide, shows up to 11% weight loss in 12 weeks with minimal side effects in early-stage trial. Read more here.

RUMMAGING through her packed wardrobe Vivienne Joy struggles to find something that still fits. Since starting Mounjaro three ...

Revenue have seized a significant amount of weight-loss drugs and other medical products purchased online recently ...